skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover Base de dados/Biblioteca: Taylor & Francis Current Content Access remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Leukemic Stem Cells: A Review
Leukemic Stem Cells: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
2
CD52 Expression in Mantle Cell Lymphoma
CD52 Expression in Mantle Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD52 Expression in Mantle Cell Lymphoma

Bass, Adam J. ; Gong, Jerald ; Nelson, Ramona ; Rizzieri, David A.

Leukemia & lymphoma, 2002, Vol.43 (2), p.339-342 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
3
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786-797 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A

Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia

Rao, Arati V. ; Younis, Islam R. ; Sand, Gregory J. ; Spasojevic, Ivan ; Adams, David J. ; Decastro, Carlos M. ; Gockerman, John P. ; Peterson, Bercedis L. ; Petros, William P. ; Moore, Joseph O. ; Rizzieri, David A.

Leukemia & lymphoma, 2008-01, Vol.49 (8), p.1523-1529 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
6
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression

Stein, Eytan M ; de Botton, Stephane ; Cluzeau, Thomas ; Pigneux, Arnaud ; Liesveld, Jane L ; Cook, Rachel J ; Rousselot, Philippe ; Rizzieri, David A ; Braun, Thorsten ; Roboz, Gail J ; Lebon, Delphine ; Heiblig, Mael ; Baker, Kristen ; Volkert, Angela ; Paul, Sofia ; Rajagopal, Nisha ; Roth, David A ; Kelly, Michael ; Peterlin, Pierre

Leukemia & lymphoma, 2023-12, Vol.64 (12), p.1992-2001 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
7
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Davis, James A. ; Rizzieri, David A. ; Lane, Andrew A. ; Taylor, Justin ; Faisal, Muhammad Salman ; Vasu, Sumithira ; Soong, Deborah ; Li, Hong ; Herbst, Amanda ; Greenwell, I. Brian

Leukemia & lymphoma, 2022-09, Vol.63 (11), p.2757-2759 [Periódico revisado por pares]

Taylor & Francis

Texto completo disponível

Citações Citado por
8
The Diverse Biological Functions of Phosphatidylinositol Transfer Proteins in Eukaryotes
The Diverse Biological Functions of Phosphatidylinositol Transfer Proteins in Eukaryotes
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Diverse Biological Functions of Phosphatidylinositol Transfer Proteins in Eukaryotes

Phillips, Scott E. ; Vincent, Patrick ; Rizzieri, Kellie E. ; Schaaf, Gabriel ; Bankaitis, Vytas A. ; Gaucher, Eric A.

Critical reviews in biochemistry and molecular biology, 2006, Vol.41 (1), p.21-49 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por
9
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis

Berdeja, Jesus G. ; Heinrich, Michael C. ; Dakhil, Shaker R. ; Goldberg, Stuart L. ; Wadleigh, Martha ; Kuriakose, Philip ; Cortes, Jorge ; Radich, Jerald ; Helton, Bret ; Rizzieri, David ; Paley, Carole ; Dautaj, Ilva ; Mauro, Michael J.

Leukemia & lymphoma, 2019-08, Vol.60 (10), p.2384-2393 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
10
Six-Month Outcomes of a Randomized, Motivational Tele-intervention for Change in the Codependent Behavior of Family Members of Drug Users
Six-Month Outcomes of a Randomized, Motivational Tele-intervention for Change in the Codependent Behavior of Family Members of Drug Users
Material Type:
Artigo 		Adicionar ao Meu Espaço

Six-Month Outcomes of a Randomized, Motivational Tele-intervention for Change in the Codependent Behavior of Family Members of Drug Users

Bortolon, Cassandra Borges ; Moreira, Taís de Campos ; Signor, Luciana ; Guahyba, Bárbara Léa ; Figueiró, Luciana Rizzieri ; Ferigolo, Maristela ; Barros, Helena Maria Tannhauser

Substance use & misuse, 2017-01, Vol.52 (2), p.164-174 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2006  (5)
  2. 2006Até2009  (15)
  3. 2010Até2013  (13)
  4. 2014Até2019  (10)
  5. Após 2019  (9)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.